Sign in
4

Changes in Ownership

OKYO Pharma Ltd Filed Acc 0001493152-26-034409

CHIEF EXECUTIVE OFFICER acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dempsey Robert John · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-07-22 Grant or award : show line 1 in the form +15,000 $1.54 $23,085 15,000 D
Loading xslF345X06/ownership.xml…